CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial
November 02, 2020 at 10:54 AM EST
German biotech CureVac said advanced clinical trials are on track to launch by the end of 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|